• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康儿童流感疫苗:一项荟萃分析。

Influenza vaccine in healthy children: a meta-analysis.

作者信息

Negri Eva, Colombo Carla, Giordano Laura, Groth Nicola, Apolone Giovanni, La Vecchia Carlo

机构信息

Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milan, Italy.

出版信息

Vaccine. 2005 Apr 22;23(22):2851-61. doi: 10.1016/j.vaccine.2004.11.053.

DOI:10.1016/j.vaccine.2004.11.053
PMID:15780733
Abstract

We conducted a meta-analysis of 13 randomised clinical trials evaluating the efficacy of influenza vaccine in healthy children. Against culture-confirmed influenza the overall efficacy was 74% (95% confidence interval, CI, 57%-84%), 65% for inactivated and 80% for live-attenuated vaccine. Corresponding figures were 59% (95% CI 43%-71%), 63% and 54% for serologically-confirmed influenza, and 33% (95% CI 29%-36%), 33% and 34% for clinical illness. Influenza vaccine is effective in preventing laboratory-confirmed and clinical influenza in healthy children, with no clear difference between inactivated and live-attenuated vaccine. Data on infants and younger children were too scanty to allow separate assessment.

摘要

我们对13项评估流感疫苗对健康儿童疗效的随机临床试验进行了荟萃分析。对于经培养确诊的流感,总体疗效为74%(95%置信区间,CI,57%-84%),灭活疫苗为65%,减毒活疫苗为80%。对于血清学确诊的流感,相应数字分别为59%(95%CI 43%-71%)、63%和54%,对于临床疾病则为33%(95%CI 29%-36%)、33%和34%。流感疫苗可有效预防健康儿童的实验室确诊流感和临床流感,灭活疫苗和减毒活疫苗之间无明显差异。关于婴儿和年幼儿童的数据太少,无法进行单独评估。

相似文献

1
Influenza vaccine in healthy children: a meta-analysis.健康儿童流感疫苗:一项荟萃分析。
Vaccine. 2005 Apr 22;23(22):2851-61. doi: 10.1016/j.vaccine.2004.11.053.
2
Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.减毒活流感疫苗在儿童中的疗效:九项随机临床试验的荟萃分析。
Vaccine. 2009 Feb 11;27(7):1101-10. doi: 10.1016/j.vaccine.2008.11.093. Epub 2008 Dec 16.
3
Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.在2003 - 2004年甲型(H3N2)流感爆发期间接种的三价减毒活鼻内流感疫苗为儿童提供了直接、间接和即时的保护。
Pediatrics. 2007 Sep;120(3):e553-64. doi: 10.1542/peds.2006-2836. Epub 2007 Aug 13.
4
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.三价减毒活疫苗冷适应流感疫苗与三价灭活流感病毒疫苗在哮喘儿童和青少年中的疗效和安全性比较。
Pediatr Infect Dis J. 2006 Oct;25(10):860-9. doi: 10.1097/01.inf.0000237797.14283.cf.
5
Duration of protection provided by live attenuated influenza vaccine in children.减毒活流感疫苗在儿童中提供的保护持续时间。
Pediatr Infect Dis J. 2008 Aug;27(8):744-8. doi: 10.1097/INF.0b013e318174e0f8.
6
The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality.流感疫苗对健康儿童的疗效:一项荟萃分析,评估疗效估计值潜在变异来源,包括研究质量。
Pediatr Infect Dis J. 2007 Feb;26(2):97-106. doi: 10.1097/01.inf.0000253053.01151.bd.
7
Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.在患有反复呼吸道感染的幼儿中,减毒活流感疫苗比灭活流感疫苗具有更高的相对效力。
Pediatr Infect Dis J. 2006 Oct;25(10):870-9. doi: 10.1097/01.inf.0000237829.66310.85.
8
Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.三价灭活流感疫苗有效性的季节内中期估计——威斯康星州马什菲尔德,2007 - 2008年流感季节
MMWR Morb Mortal Wkly Rep. 2008 Apr 18;57(15):393-8.
9
Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.病毒体亚单位流感疫苗在预防3至14岁儿童流感相关疾病中的有效性及其社会和经济后果:一项前瞻性队列研究。
Vaccine. 2006 Nov 10;24(44-46):6638-42. doi: 10.1016/j.vaccine.2006.05.034. Epub 2006 Jun 6.
10
Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.美国24至59个月大儿童中减毒活流感疫苗与灭活流感疫苗的成本效益
Vaccine. 2008 Jun 2;26(23):2841-8. doi: 10.1016/j.vaccine.2008.03.046. Epub 2008 May 6.

引用本文的文献

1
Transcriptomic Analysis Reveals Sixteen Potential Genes Associated with the Successful Differentiation of Antibody-Secreting Cells through the Utilization of Unfolded Protein Response Mechanisms in Robust Responders to the Influenza Vaccine.转录组分析揭示了16个潜在基因,这些基因与流感疫苗强应答者通过利用未折叠蛋白反应机制成功分化抗体分泌细胞有关。
Vaccines (Basel). 2024 Jan 29;12(2):136. doi: 10.3390/vaccines12020136.
2
Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review.儿童鼻内减毒活流感疫苗的成本效益:一项系统评价
Vaccines (Basel). 2022 Sep 4;10(9):1466. doi: 10.3390/vaccines10091466.
3
Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines.
活流感疫苗临床试验中神经氨酸酶抑制抗体的研究
Antibodies (Basel). 2020 May 29;9(2):20. doi: 10.3390/antib9020020.
4
Statement on Seasonal Influenza Vaccine for 2013-2014: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).2013 - 2014年季节性流感疫苗声明:免疫国家咨询委员会(NACI)的咨询委员会声明(ACS)
Can Commun Dis Rep. 2013 Oct 10;39(ACS-4):1-37. doi: 10.14745/ccdr.v39i00a04.
5
STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2012-2013: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).2012 - 2013年季节性流感疫苗声明:免疫国家咨询委员会(NACI)的咨询委员会声明(ACS)
Can Commun Dis Rep. 2012 Aug 1;38(ACS-2):1-36. doi: 10.14745/ccdr.v38i00a02.
6
Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).关于2010 - 2011年季节性三价灭活流感疫苗(TIV)的声明:免疫国家咨询委员会(NACI)的咨询委员会声明(ACS)
Can Commun Dis Rep. 2010 Aug 31;36(ACS-6):1-49. doi: 10.14745/ccdr.v36i00a06.
7
Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).2011 - 2012年季节性流感疫苗声明:免疫国家咨询委员会(NACI)的咨询委员会声明(ACS)
Can Commun Dis Rep. 2011 Oct 14;37(ACS-5):1-55. doi: 10.14745/ccdr.v37i00a05.
8
[The universal influenza vaccination in children with Vaxigrip Tetra in Italy: an evaluation of Health Technology Assessment].[意大利使用Vaxigrip Tetra对儿童进行通用流感疫苗接种:卫生技术评估]
J Prev Med Hyg. 2018 May 30;59(1 Suppl 1):E1-E86. eCollection 2018 May.
9
Vaccines for preventing influenza in healthy children.用于预防健康儿童流感的疫苗。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004879. doi: 10.1002/14651858.CD004879.pub5.
10
MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.基于微小RNA的流感病毒在易感宿主中的减毒作用
J Virol. 2018 Jan 2;92(2). doi: 10.1128/JVI.01741-17. Print 2018 Jan 15.